BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 14764674)

  • 1. Transgenic expression of a human polyreactive Ig expressed in chronic lymphocytic leukemia generates memory-type B cells that respond to nonspecific immune activation.
    Widhopf GF; Brinson DC; Kipps TJ; Tighe H
    J Immunol; 2004 Feb; 172(4):2092-9. PubMed ID: 14764674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: altered differentiation and an accelerated response.
    Santulli-Marotto S; Qian Y; Ferguson S; Clarke SH
    J Immunol; 2001 Apr; 166(8):5292-9. PubMed ID: 11290816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for somatic selection of natural autoantibodies.
    Martin T; Duffy SF; Carson DA; Kipps TJ
    J Exp Med; 1992 Apr; 175(4):983-91. PubMed ID: 1552291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A VH11V kappa 9 B cell antigen receptor drives generation of CD5+ B cells both in vivo and in vitro.
    Chumley MJ; Dal Porto JM; Kawaguchi S; Cambier JC; Nemazee D; Hardy RR
    J Immunol; 2000 May; 164(9):4586-93. PubMed ID: 10779761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging-dependent exclusion of antigen-inexperienced cells from the peripheral B cell repertoire.
    Johnson SA; Rozzo SJ; Cambier JC
    J Immunol; 2002 May; 168(10):5014-23. PubMed ID: 11994453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone.
    Chen X; Martin F; Forbush KA; Perlmutter RM; Kearney JF
    Int Immunol; 1997 Jan; 9(1):27-41. PubMed ID: 9043945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a V region-less B cell receptor confers a tolerance-like phenotype on transgenic B cells.
    Corcos D; Grandien A; Vazquez A; Dunda O; Lorès P; Bucchini D
    J Immunol; 2001 Mar; 166(5):3083-9. PubMed ID: 11207259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic and isotypic light chain inclusion in peripheral B cells from anti-DNA antibody transgenic C57BL/6 and BALB/c mice.
    Witsch EJ; Bettelheim E
    J Immunol; 2008 Mar; 180(6):3708-18. PubMed ID: 18322176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein.
    Litzenburger T; Blüthmann H; Morales P; Pham-Dinh D; Dautigny A; Wekerle H; Iglesias A
    J Immunol; 2000 Nov; 165(9):5360-6. PubMed ID: 11046072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of B cells expressing a human immunoglobulin M rheumatoid factor autoantibody in transgenic mice.
    Tighe H; Chen PP; Tucker R; Kipps TJ; Roudier J; Jirik FR; Carson DA
    J Exp Med; 1993 Jan; 177(1):109-18. PubMed ID: 8418195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors.
    Kenny JJ; Rezanka LJ; Lustig A; Fischer RT; Yoder J; Marshall S; Longo DL
    J Immunol; 2000 Apr; 164(8):4111-9. PubMed ID: 10754305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural anti-intestinal goblet cell autoantibody production from marginal zone B cells.
    Ichikawa D; Asano M; Shinton SA; Brill-Dashoff J; Formica AM; Velcich A; Hardy RR; Hayakawa K
    J Immunol; 2015 Jan; 194(2):606-14. PubMed ID: 25480561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa editing rescues autoreactive B cells destined for deletion in mice transgenic for a dual specific anti-laminin Ig.
    Brady GF; Congdon KL; Clark AG; Sackey FN; Rudolph EH; Radic MZ; Foster MH
    J Immunol; 2004 May; 172(9):5313-21. PubMed ID: 15100270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene dose-dependent maturation and receptor editing of B cells expressing immunoglobulin (Ig)G1 or IgM/IgG1 tail antigen receptors.
    Pogue SL; Goodnow CC
    J Exp Med; 2000 Mar; 191(6):1031-44. PubMed ID: 10727464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic human lambda 5 rescues the murine lambda 5 nullizygous phenotype.
    Donohoe ME; Beck-Engeser GB; Lonberg N; Karasuyama H; Riley RL; Jäck HM; Blomberg BB
    J Immunol; 2000 May; 164(10):5269-76. PubMed ID: 10799888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance through indifference: autoreactive B cells to the nuclear antigen La show no evidence of tolerance in a transgenic model.
    Aplin BD; Keech CL; de Kauwe AL; Gordon TP; Cavill D; McCluskey J
    J Immunol; 2003 Dec; 171(11):5890-900. PubMed ID: 14634099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of a recombined Ig heavy chain transgene in B-lineage cells of transgenic mice.
    Heinzelmann A; Kumar S; Noggle S; Goedegebuur I; Sauer KM; Rath S; Durdik JM
    J Immunol; 1998 Jul; 161(2):666-73. PubMed ID: 9670941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid induction of splenic and peritoneal B-1a cells in adult mice by thymus-independent type-2 antigen.
    Whitmore AC; Neely HR; Diz R; Flood PM
    J Immunol; 2004 Nov; 173(9):5406-14. PubMed ID: 15494487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negligible class II MHC presentation of B cell receptor-derived peptides by high density resting B cells.
    Snyder CM; Zhang X; Wysocki LJ
    J Immunol; 2002 Apr; 168(8):3865-73. PubMed ID: 11937540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive surface B cell antigen receptor down-regulation accompanies efficient development of antinuclear antigen B cells to mature, follicular phenotype.
    Heltemes-Harris L; Liu X; Manser T
    J Immunol; 2004 Jan; 172(2):823-33. PubMed ID: 14707052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.